Table 1. Characteristics of 303 Arizona CoVHORT participants with lab confirmed positive COVID-19 test, with 30 or more days of follow-up, from 28 May 2020 to 24 February 2021.
Characteristic | Total (n = 303) | PASC (n = 208) | No PASC (n = 95) | p-valuea |
---|---|---|---|---|
Follow-up (d), median (IQR) | 61 (50, 85) | 62 (53, 88) | 57 (48, 80) | 0.005 |
Age (y), mean (SD) | 43.6 (16.6) | 43.8 (15.8) | 43.1 (18.2) | 0.73 |
Female gender, n(%) | 212 (70.0) | 152 (73.1) | 60 (63.2) | 0.07 |
Race/ethnicity | 0.70 | |||
Hispanic | 69 (22.8) | 50 (24.0) | 19 (20.0) | |
Non-Hispanic White | 205 (67.7) | 139 (66.8) | 69 (72.6) | |
Other race | 19 (6.3) | 14 (6.7) | 5 (5.3) | |
Education | 0.0009 | |||
Some college or less | 44 (14.5) | 39 (18.8) | 5 (5.3) | |
College or more | 115 (38.0) | 72 (34.6) | 43 (45.3) | |
Missing | 144 (47.5) | 97 (46.6) | 47 (49.5) | |
BMI (kg/m2), mean (SD) | 28.0 (7.0) | 28.5 (7.3) | 26.9 (6.2) | 0.08 |
Currently smokes or vapes | 40 (12.7) | 27 (12.2) | 13 (13.7) | 0.72 |
Any pre-existing chronic condition b | 203 (67.0) | 148 (71.2) | 55 (57.9) | 0.02 |
Seasonal allergies | 127 (41.9) | 97 (46.6) | 30 (31.6) | 0.01 |
Asthma | 48 (15.8) | 31 (14.9) | 17 (17.9) | 0.51 |
Hypertension | 45 (14.9) | 34 (16.3) | 10 (10.5) | 0.28 |
COVID-19 severityc, mean (SD) | 4.6 (2.4) | 5.1 (2.4) | 3.4 (1.9) | <0.0001 |
Percentages may not add to 100% due to rounding and missing data. BMI = body mass index. PASC = post-acute sequalae of COVID-19, defined as any symptom reported at ≥30 days follow-up.
a For the test of any reported symptom vs no reported symptom amongst non-missing values.
b Self-reported pre-existing chronic conditions include: Thyroid disorder, asthma, chronic obstructive pulmonary disease, valley fever, emphysema, seasonal allergies, diabetes, pre-diabetes, cancer, heart disease, high blood pressure, liver disease, kidney disease, gastrointestinal conditions, depression/anxiety, autoimmune diseases.
c Self-reported COVID-19 severity based on a scale from 1–10.